[Federal Register Volume 68, Number 35 (Friday, February 21, 2003)]
[Notices]
[Pages 8513-8514]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-4060]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol 
Effect: Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following Federal advisory committee 
meeting.
    Name: National Task Force on Fetal Alcohol Syndrome and Fetal 
Alcohol Effect (NTFFASFAE).
    Times and Dates: 8:30 a.m.-4 p.m., March 13, 2003. 8:30 a.m.-11:45 
a.m., March 14, 2003.
    Place: Doubletree Hotel Atlanta/Buckhead, 3342 Peachtree Road, NE.,

[[Page 8514]]

Atlanta, Georgia 30326, telephone 404/231-1234, fax 404/231-3112.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 65 people.
    Purpose: The Secretary is authorized by the Public Health Service 
Act, Section 399G, (42 U.S.C. Section 280f, as added by Public Law 105-
392) to establish a National Task Force on Fetal Alcohol Syndrome and 
Fetal Alcohol Effect to:
    (1) Foster coordination among all governmental agencies, academic 
bodies and community groups that conduct or support Fetal Alcohol 
Syndrome (FAS) and Fetal Alcohol Effect (FAE) research, programs and 
surveillance; and (2) to otherwise meet the general needs of 
populations actually or potentially impacted by FAS and FAE.
    Matters to Be Discussed: Agenda items include: an update from the 
National Center on Birth Defects and Developmental Disabilities 
Scientific Working Group on Diagnostic Guidelines for FAS and Alcohol-
Related Neurodevelopmental Disabilities (ARND); an update on activities 
from the Interagency Coordinating Committee on Fetal Alcohol Syndrome; 
new research and program updates from the CDC and other Federal 
agencies; and working group updates. Additional agenda items include: 
task force discussions on the use of the term fetal alcohol spectrum 
disorders: What is it? When is it appropriate to use it?; provider 
education and FAS prevention; development of a clear message for 
pediatricians, nurses, and other providers: how the FAS diagnosis will 
benefit the child and family; future topics, and scheduling the next 
meeting.
    Agenda items are subject to change as priorities dictate.

CONTACT PERSON FOR MORE INFORMATION: R. Louise Floyd, DSN, RN, 
Designated Federal Official, National Center on Birth Defects and 
Developmental Disabilities, CDC, 4700 Buford Highway, NE, (F-49), 
Atlanta, Georgia 30333, telephone 770/488-7372, fax 770/488-7361.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both the CDC and ATSDR.

    Dated: February 13, 2003.
Joseph E. Salter,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 03-4060 Filed 2-20-03; 8:45 am]
BILLING CODE 4163-18-P